Page 14 - Topline News Today

LIFT Home study evaluated the safety and feasibility of ARC-EX Therapy in the home setting 100% of subjects completed the study with no reported serious adverse events 97% of therapy sessions

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced Tuesday positive topline results from the Phase 3 TALAPRO-2 study of TALZENNA (talazoparib) plus XTANDI in men with metastatic castration-resistant

Up-LIFT study achieves primary endpoint: Statistically significant and clinically meaningful improvement in upper extremity strength and functioni Improvement in arm and hand function is the highest

TopLine’s 19th annual school supply drive benefits local communities...

Results show a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients Top

Fourteen years after he retired from the Tucson Police Department, Bob Webster found himself yet again staring down a 40-plus hour training session alongside some familiar faces in the classroom

Topline Energy partners with US-based firm to build LNG hub in Cebu

Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update - Seralutinib Phase 2 TORREY Study on track for topline readout in second half of... | August 9, 2022

Positive topline data in the Phase 2 BrigHtn trial, demonstrating clinically meaningful and statistically significant reduction in blood pressure with baxdrostat in treatment-resistant hypertension ... | August 8, 2022

Excelerate Energy and Topline Energy partner together to build an LNG Hub in Cebu